INMB · Inmune Bio, Inc. · Short Volume
$0.89
0.00 (-0.47%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20
7246
Avg daily vol (3M)
342.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-11-19 | 143,267 | 13,669 | 205,297 | 69.8% |
| 2026-11-18 | 211,011 | 0 | 292,699 | 72.1% |
| 2026-11-17 | 216,805 | 3,060 | 339,988 | 63.8% |
| 2026-11-16 | 152,824 | 1,275 | 308,923 | 49.5% |
| 2026-11-13 | 144,057 | 0 | 329,181 | 43.8% |
| 2026-11-12 | 162,292 | 0 | 278,152 | 58.3% |
| 2026-11-11 | 111,506 | 0 | 163,092 | 68.4% |
| 2026-11-10 | 85,633 | 0 | 211,145 | 40.6% |
| 2026-11-09 | 127,177 | 5,800 | 339,882 | 37.4% |
| 2026-11-06 | 89,980 | 64,300 | 468,534 | 19.2% |
| 2026-11-05 | 178,573 | 65,541 | 311,438 | 57.3% |
| 2026-11-04 | 91,962 | 0 | 158,663 | 58.0% |
| 2026-11-03 | 51,259 | 278 | 72,622 | 70.6% |
| 2026-11-02 | 48,811 | 6,277 | 114,046 | 42.8% |
| 2026-10-30 | 30,586 | 23 | 90,620 | 33.8% |
| 2026-10-29 | 53,189 | 18 | 101,346 | 52.5% |
| 2026-10-28 | 25,550 | 0 | 97,072 | 26.3% |
| 2026-10-27 | 79,680 | 766 | 179,995 | 44.3% |
| 2026-10-26 | 55,183 | 300 | 102,524 | 53.8% |
| 2026-10-23 | 37,288 | 200 | 129,126 | 28.9% |
| 2026-10-22 | 78,818 | 0 | 149,168 | 52.8% |
| 2026-10-21 | 54,176 | 0 | 95,265 | 56.9% |
| 2026-10-20 | 27,401 | 0 | 39,494 | 69.4% |
| 2026-10-19 | 45,050 | 0 | 91,612 | 49.2% |
| 2026-10-16 | 53,898 | 3,604 | 107,287 | 50.2% |
| 2026-10-15 | 154,429 | 6,002 | 405,438 | 38.1% |
| 2026-10-14 | 433,926 | 500 | 671,587 | 64.6% |
| 2026-10-13 | 90,500 | 0 | 150,792 | 60.0% |
| 2026-10-12 | 13,651 | 0 | 51,198 | 26.7% |
| 2026-10-09 | 31,396 | 0 | 44,095 | 71.2% |
| 2026-10-08 | 104,764 | 830 | 155,435 | 67.4% |
| 2026-10-07 | 26,529 | 0 | 50,501 | 52.5% |
| 2026-10-06 | 70,211 | 0 | 119,929 | 58.5% |
| 2026-10-05 | 140,847 | 0 | 155,844 | 90.4% |
| 2026-10-02 | 52,297 | 0 | 87,681 | 59.6% |
| 2026-10-01 | 115,983 | 1,118 | 170,613 | 68.0% |
| 2026-09-30 | 50,408 | 0 | 87,359 | 57.7% |
| 2026-09-29 | 97,469 | 0 | 169,584 | 57.5% |
| 2026-09-28 | 29,381 | 0 | 70,376 | 41.7% |
| 2026-09-25 | 71,750 | 0 | 105,305 | 68.1% |
| 2026-09-24 | 32,025 | 0 | 65,323 | 49.0% |
| 2026-09-23 | 179,332 | 0 | 291,027 | 61.6% |
| 2026-09-22 | 56,964 | 341 | 191,274 | 29.8% |
| 2026-09-21 | 52,533 | 1,404 | 171,917 | 30.6% |
| 2026-09-18 | 114,550 | 47 | 264,931 | 43.2% |
| 2026-09-17 | 75,470 | 8,911 | 204,745 | 36.9% |
| 2026-09-16 | 269,805 | 29,005 | 497,502 | 54.2% |
| 2026-09-15 | 141,726 | 3 | 195,944 | 72.3% |
| 2026-09-14 | 88,719 | 998 | 222,765 | 39.8% |
| 2026-09-11 | 74,745 | 4,752 | 135,010 | 55.4% |
Showing 1–50 of 65 days
Key facts
CIK
1711754
CUSIP
45782T105
13F (30d)
70 filings
58 filers
Visit website
Investor relations